Manufacturing / Pharmaceutical Preparations
Abivax S.A.
ABVX
$87.85
-$1.39 (-1.56%)
Price as of Oct 9, 2026 17:01 UTC
8.1 B
Market Cap (Mid Cap)
16%
IV Rank
64.0%
Implied Volatility
Technical Signals
as of Oct 7
Bearish
0 of 7
Trend
- Above 20-day average $98.87
- Above 50-day average $107.91
- Above 200-day average $113.60 · -23.4%
- Moving averages stacked Not aligned
Momentum
- Golden cross (50/200) Down · 10d ago
- Momentum cross (20/50) Down · 31d ago
Volume
- Below-average volume 1.0x avg
Price & Trend
Daily candles with EMA 20, SMA 50. Drag to zoom.
Options Activity & Greeks
Implied volatility, flow, and dealer positioning from the options market.
Put/Call Ratio
0.48
Bullish skew
Implied Volatility
64.0%
0% percentile
IV vs Realized
Options rich
30d HV 48.0%
Options Heat Map
Delta-risk grid for ABVX options across strikes and expirations. Hover any cell for full Greeks.
Loading option chain data...
Insider Trades
0 buys
0 sells
| Date | Insider | Title | Type | Shares | Value | Since Trade |
|---|---|---|---|---|---|---|
| Mar 19, 2026 | marc de garidel thoron | Other | 35,456 | $0 | -27.6% | |
| Feb 17, 2026 | Dominik Hochli | Other | 2,471 | $49,988 | +340.2% | |
| Feb 13, 2026 | Camilla Soenderby | Other | 7,661 | $154,982 | +340.2% | |
| Feb 13, 2026 | June Kim | Other | 7,414 | $149,985 | +340.2% | |
| Feb 01, 2026 | marc de garidel thoron | Other | 217,728 | $0 | -20.1% | |
| Jan 13, 2026 | SOFINNOVA PARTNERS SAS | Other | 50,000 | $6,046,775 | -26.4% | |
| Jan 12, 2026 | SOFINNOVA PARTNERS SAS | Other | 950,000 | $116,287,505 | -27.3% | |
| Dec 11, 2025 | marc de garidel thoron | Other | 17,728 | $0 | -33.1% | |
| Nov 29, 2025 | Corinna zur Bonsen-Thomas | Other | 4,863 | $63,705 | +579.8% | |
| Nov 13, 2025 | marc de garidel thoron | Other | 35,456 | $0 | -11.7% |
Earnings History
| Date | Quarter | EPS Est. | EPS Actual | Surprise | Result |
|---|---|---|---|---|---|
| May 25, 2026 | Q1 2026 | ||||
| Dec 31, 2025 | Q4 2025 | -$1.52 | -$3.24 | -112.5% | Miss |
| Jun 30, 2025 | Q2 2025 | -$1.58 | -$1.59 | -0.6% | Miss |
| Dec 31, 2024 | Q4 2024 | -$1.37 | -$1.50 | -9.7% | Miss |
| Jun 30, 2024 | Q2 2024 | -$1.39 | -$1.29 | +7.0% | Beat |
Track ABVX with ThetaPal
Get insider trade alerts, AI portfolio analysis, and options roll recommendations for ABVX and your entire portfolio.